26 August 2020
Conventional co-cultures have shed light on several aspects of cancer immunobiology, but they are limited by the lack of physiological complexity. Fidgor and colleagues have developed a human organotypic skin melanoma culture (OMC) that makes it possible to study host malignant cell interactions within a multicellular tissue architecture in real-time.
By co-culturing decellular dermis with keratinocytes, fibroblasts, and immune cells in the presence of melanoma cells, Figdor and colleagues have generated a reconstructed TME that closely resembles tumor growth as observed in human lesions and supports cell survival and function.
Figdor and colleagues demonstrated that the OMC is suitable for and outperforms conventional 2D co-cultures for the study of TME-imprinting mechanisms. Within the OMC they observed the tumor-driven conversion of cDC2s into CD14+ DCs, characterized by an immunosuppressive phenotype. The OMC offers a valuable approach to study how TME affects the immune system.
full article
Carl Figdor and colleagues from the theme of Cancer Development and Immune Defense, showed in Nature Communications that the tumor microenvironment (TME) forms a major obstacle to effective cancer treatment and the clinical success of immunotherapy.
Conventional co-cultures have shed light on several aspects of cancer immunobiology, but they are limited by the lack of physiological complexity. Fidgor and colleagues have developed a human organotypic skin melanoma culture (OMC) that makes it possible to study host malignant cell interactions within a multicellular tissue architecture in real-time.
By co-culturing decellular dermis with keratinocytes, fibroblasts, and immune cells in the presence of melanoma cells, Figdor and colleagues have generated a reconstructed TME that closely resembles tumor growth as observed in human lesions and supports cell survival and function.
Figdor and colleagues demonstrated that the OMC is suitable for and outperforms conventional 2D co-cultures for the study of TME-imprinting mechanisms. Within the OMC they observed the tumor-driven conversion of cDC2s into CD14+ DCs, characterized by an immunosuppressive phenotype. The OMC offers a valuable approach to study how TME affects the immune system.
full article
Related news items
T cell immunity is directed by tetraspanin CD53
5 July 2022 T cells are immune cells that are key for the defense against pathogens and cancer. T cells depend on the membrane protein CD45 to initiate T cell receptor signaling, but how CD45 is controlled at the molecular level is poorly understood. read moreA single protein complex balances the very first lineage decision of cells in human: towards foetus or placenta
21 June 2022 The international group of researchers spearheaded by Dick Zijlmans and Hendrik Marks together with colleagues from KU Leuven, examined which proteins are associated with the chromatin and how this affects gene transcription. read moreDutch Society of Clinical Chemistry Science & Innovation Award for the team of Hans Jacobs
14 June 2022 The team of Hans Jacobs pioneers on the development of personalized diagnostics to measure minimal residual disease in patients with multiple myeloma. read moreEuropean grants for groundbreaking Radboudumc research Professors Roshan Cools and Peter Friedl receive ERC Advanced Grant
26 April 2022The European Research Council (ERC) is awarding grants to Roshan Cools and Peter Friedl, both professors at Radboudumc. While Cools will investigate how brains control behaviour in (stressful) situations, Friedl will work on developing a new cancer therapy.
read more